Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic Spinal Reflexes01:22

Somatic Spinal Reflexes

7.8K
Somatic spinal reflexes are rapid, involuntary muscular responses to external stimuli that involve the somatic musculature and the spinal cord.
One of the most well-known somatic spinal reflexes is the stretch reflex, which is activated by the sudden stretching of a muscle. This reflex involves the activation of specialized sensory receptors called muscle spindles, which are located in the muscle tissue and detect changes in the length and speed of muscle contractions. When a muscle is suddenly...
7.8K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

1.0K
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

967
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Piaget's Stage 1 of Cognitive Development01:14

Piaget's Stage 1 of Cognitive Development

2.7K
The sensorimotor stage, the initial phase of Jean Piaget's theory of cognitive development, spans the first two years of a child's life. During this period, infants actively engage with their surroundings, building cognitive awareness through direct interaction with the world. This interaction is primarily based on sensory perception and motor actions, allowing infants to gradually understand basic physical properties and predict how objects interact within their environment.
Exploration...
2.7K
Socioemotional Development during Infancy01:30

Socioemotional Development during Infancy

1.4K
Socio-emotional development in infancy is primarily shaped by early emotional responses and social connections, with temperament playing a central role. Temperament refers to the consistent patterns in an individual's emotional and behavioral responses, observable even in infancy. By examining temperament, researchers can better understand an infant's unique ways of interacting with the world, influencing subsequent personality and socio-emotional growth.
Primary Temperament Types
1.4K
Development of Human Microbiota01:30

Development of Human Microbiota

61
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
61

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Where Did this Come From: Lumbar Puncture for All Infants with Suspected Tuberculosis Disease?

Journal of the Pediatric Infectious Diseases Society·2026
Same author

I Zinc, Therefore I Am: Context is Key.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

The Duration Dilemma: With and Without Definitive Diagnostics.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG·2026
Same author

Association of Intended Mode of Delivery With Neonatal and Maternal Outcomes at 22-25 Weeks of Gestation.

O&G open·2026
Same author

Executive Summary: State-of-the-Art Review: Infectious Diarrhea.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

State-of-the-Art Review: Infectious Diarrhea.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026
Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
08:27

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

11.6K

Neonatal sepsis.

Andi L Shane1, Pablo J Sánchez2, Barbara J Stoll3

  • 1Division of Infectious Disease, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA.

Lancet (London, England)
|April 25, 2017
PubMed
Summary
This summary is machine-generated.

Neonatal sepsis causes significant illness and death, with varying burden estimates globally. Ongoing research focuses on diagnostics and prevention to reduce this critical infant health issue.

More Related Videos

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

11.9K
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

7.0K

Related Experiment Videos

Last Updated: May 5, 2026

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
08:27

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

11.6K
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

11.9K
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

7.0K

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pediatrics

Background:

  • Neonatal sepsis is a major cause of infant morbidity and mortality worldwide.
  • Disease burden estimates for neonatal sepsis differ significantly between high-income and low-to-middle-income countries.
  • Clinical presentation varies from subclinical infection to severe systemic disease, influenced by pathogen, infant immunity, and exposure factors.

Purpose of the Study:

  • To review the multifaceted aspects of neonatal sepsis, including its epidemiology, clinical manifestations, and contributing factors.
  • To highlight the challenges in diagnosing and managing neonatal sepsis, particularly in vulnerable infant populations.
  • To discuss current and emerging strategies for the prevention and control of neonatal sepsis.

Main Methods:

  • Literature review of neonatal sepsis epidemiology, pathogenesis, clinical presentation, and management strategies.
  • Analysis of factors influencing disease expression, including immunological immaturity and hospital-acquired infections.
  • Examination of advancements in diagnostics and preventive measures.

Main Results:

  • Neonatal sepsis burden varies by geographical setting and socioeconomic status.
  • Premature infants with prolonged hospital stays and invasive procedures are at higher risk.
  • Clinical diagnosis can be challenging, irrespective of pathogen identification.

Conclusions:

  • Effective management of neonatal sepsis requires understanding diverse risk factors and varied clinical presentations.
  • Advancements in culture-independent diagnostics, sepsis prediction scores, and maternal vaccines are crucial for reducing neonatal sepsis burden.
  • Addressing immunological immaturity and hospital-acquired infections is key to improving outcomes for neonates.